POST-TRANSPLANTATION CYCLOPHOSPHAMIDE FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR HIGHER-RISK MYELODYSPLASTIC SYNDROME

被引：0
|
作者：
Choi, E. -J. [1 ]
Park, H. -S. [1 ]
Lee, J. -H. [1 ]
Lee, K. -H. [1 ]
Lee, J. -H. [1 ]
机构：
[1] Univ Ulsan, Dept Hematol, Asan Med Ctr, Coll Med, Seoul, South Korea
来源：
LEUKEMIA RESEARCH | 2021年 / 108卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P58
引用
下载
收藏
页码：S49 / S49
页数：1
相关论文
共 50 条
  • [1] Post-Transplantation Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in Allogeneic Hematopoietic Cell Transplantation for Higher-Risk Myelodysplastic Syndrome
    Choi, Eun-Ji
    Park, Han-Seung
    Lee, Jung-Hee
    Lee, Kyoo Hyung
    Lee, Youngshin
    Kang, Young-Ah
    Jeon, Mijin
    Woo, Ji Min
    Kang, Hyeran
    Lee, Je-Hwan
    BLOOD, 2021, 138
  • [2] Haploidentical Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Post-Transplantation Cyclophosphamide Graft-versus-Host Disease Prophylaxis
    Castagna, Luca
    Mussetti, Alberto
    Devillier, Raynier
    Dominietto, Alida
    Marcatti, Magda
    Milone, Giuseppe
    Maura, Francesco
    de Philippis, Chiara
    Bruno, Benedetto
    Furst, Sabine
    Blaise, Didier
    Corradini, Paolo
    Montefusco, Vittorio
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (09) : 1549 - 1554
  • [3] Lower incidence of acute graft-versus-host disease with post-transplantation cyclophosphamide compared to anti-thymocyte globulin in higher-risk myelodysplastic syndrome
    Choi, Eun-Ji
    Han, Jin-Hee
    Park, Hyunkyung
    Park, Han-Seung
    Choi, Yunsuk
    Lee, Jung-Hee
    Lee, Kyoo-Hyung
    Lee, Young-Shin
    Kang, Young-Ah
    Jeon, Mijin
    Kang, Hyeran
    Woo, Ji Min
    Lee, Je-Hwan
    BONE MARROW TRANSPLANTATION, 2024, 59 (09) : 1329 - 1331
  • [4] Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis
    Hamadani, Mehdi
    Zhang, Mei-Jie
    Tang, Xiao-Ying
    Fei, Mingwei
    Brunstein, Claudio
    Chhabra, Saurabh
    D'Souza, Anita
    Milano, Filippo
    Phelan, Rachel
    Saber, Wael
    Shaw, Bronwen E.
    Weisdorf, Daniel
    Devine, Steven M.
    Horowitz, Mary M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (07) : 1312 - 1317
  • [5] Absence of Post-Transplantation Lymphoproliferative Disorder after Allogeneic Blood or Marrow Transplantation Using Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis
    Kanakry, Jennifer A.
    Kasamon, Yvette L.
    Bolanos-Meade, Javier
    Borrello, Ivan M.
    Brodsky, Robert A.
    Fuchs, Ephraim J.
    Ghosh, Nilanjan
    Gladstone, Douglas E.
    Gocke, Christopher D.
    Huff, Carol Ann
    Kanakry, Christopher G.
    Luznik, Leo
    Matsui, William
    Mogri, Huzefa J.
    Swinnen, Lode J.
    Symons, Heather J.
    Jones, Richard J.
    Anibinder, Richard E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (10) : 1514 - 1517
  • [6] Post-transplantation cyclophosphamide compared to graft-versus-host disease prophylaxis with ATG in mismatched unrelated donor hematopoietic stem cell transplantation
    Soltermann, Yves
    Heim, Dominik
    Baldomero, Helen
    Medinger, Michael
    Halter, Jorg P.
    Passweg, Jakob P.
    Kleber, Martina
    BONE MARROW TRANSPLANTATION, 2018, 53 : 75 - 76
  • [7] Letermovir for Prevention of Cytomegalovirus Reactivation in Haploidentical and Mismatched Adult Donor Allogeneic Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis
    Lin, Andrew
    Flynn, Jessica
    DeRespiris, Lauren
    Figgins, Bradley
    Griffin, Meagan
    Lau, Carmen
    Proli, Anthony
    Devlin, Sean M.
    Cho, Christina
    Tamari, Roni
    Jakubowski, Ann A.
    Papadopoulos, Esperanza B.
    Giralt, Sergio A.
    Perales, Miguel-Angel
    Seo, Susan K.
    Shaffer, Brian
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (01):
  • [8] Post-Transplantation CyclophosphamideBased Graft-versus-Host Disease Prophylaxis
    Bolanos-Meade, J.
    Hamadani, M.
    Wu, J.
    Al Malki, M. M.
    Martens, M. J.
    Runaas, L.
    Elmariah, H.
    Rezvani, A. R.
    Gooptu, M.
    Larkin, K. T.
    Shaffer, B. C.
    El Jurdi, N.
    Loren, A. W.
    Solh, M.
    Hall, A. C.
    Alousi, A. M.
    Jamy, O. H.
    Perales, M. -A.
    Yao, J. M.
    Applegate, K.
    Bhatt, A. S.
    Kean, L. S.
    Efebera, Y. A.
    Reshef, R.
    Clark, W.
    DiFronzo, N. L.
    Leifer, E.
    Horowitz, M. M.
    Jones, R. J.
    Holtan, S. G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (25): : 2338 - 2348
  • [9] Post-transplantation cyclophosphamide versus conventional graft-versus-host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantation
    Mehta, Rohtesh S.
    Saliba, Rima M.
    Chen, Julianne
    Rondon, Gabriela
    Hammerstrom, Aimee E.
    Alousi, Amin
    Qazilbash, Muzaffar
    Bashir, Qaiser
    Ahmed, Sairah
    Popat, Uday
    Hosing, Chitra
    Khouri, Issa
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Ciurea, Stefan O.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 (03) : 444 - 455
  • [10] Tocilizumab for Cytokine Release Syndrome Management After Haploidentical Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis
    Yao, Janny M.
    Otoukesh, Salman
    Kim, Hanna
    Yang, Dongyun
    Mokhtari, Sally
    Samara, Yazeed
    Blackmon, Amanda
    Arslan, Shukaib
    Agrawal, Vaibhav
    Pourhassan, Hoda
    Amanam, Idoroenyi
    Ball, Brian
    Koller, Paul
    Salhotra, Amandeep
    Becker, Pamela
    Curtin, Peter
    Artz, Andrew
    Aldoss, Ibrahim
    Ali, Haris
    Stewart, Forrest
    Smith, Eileen
    Stein, Anthony
    Marcucci, Guido
    Forman, Stephen J.
    Nakamura, Ryotaro
    Al Malki, Monzr M.
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (08): : 515e1 - 515e7
12345